Difference between revisions of "Part:BBa K5398002"
(→Usage and Biology) |
(→Usage and Biology) |
||
Line 60: | Line 60: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
<html> | <html> | ||
− | <p>In our project, given the positive correlation between number of repeat units and magnitude of cohesive force, we designed a circular mRNA on which the OFR of TRn5 (<a href="https://parts.igem.org/Part:BBa_K5398001"> BBa_K5398001 | + | <p>In our project, given the positive correlation between number of repeat units and magnitude of cohesive force, we designed a circular mRNA on which the OFR of TRn5 (<a href="https://parts.igem.org/Part:BBa_K5398001"> BBa_K5398001</a>) between the 3' and 5' intron of <i>td</i> gene from T4 phage (BBa_K5398002 and BBa_K5398003). This strategy could use short sequences to express highly repetitive squid ring teeth proteins. A self-cleaving RNA cyclase ribozyme was incorporated to form the circular mRNAs, allowing ribosomes to repeatedly translate the sequence of interest and producing proteins with different repeat numbers, thus we could obtain proteins with exceptional self-healing properties.</p> |
</html> | </html> | ||
Revision as of 16:57, 20 September 2024
The 5' intron of td gene from T4 phage
This part is a component of the td intron (5' side), an intron of the td gene from T4 phage belonging to group I introns, which can form a circular mRNA (cmRNA) to make the ribosomes repeatedly translate the extron. This year, we utilized the td intron to produce the squid ring proteins with various long tandem repeats.
We expored different production and purification strategies of target protein produced by cmRNA and examined the function of protein. Simultaneously, we also test the optimal nucleotide length of the td exon between the 5' and 3' intron.
Contents
Introduction
Due to special internal structure, the td intron, also called RNA cyclase ribozyme, can splice themselves out without assistance from the spliceosome or other proteins, and instead rely on a free guanosine nucleotide to initiate the splicing reaction in vivo. This process results in joining of the flanking exons and circularization of the intervening intron to produce an intronic circRNA (Fig. 1). So it is a strategy to produce circular RNAs in vivo.
Fig. 1 Mechanism of group I introns. (GOMES R M O da S et al. 2024)
Fig. 2 Design of a circular mRNA based on td flanking introns.
Usage and Biology
In our project, given the positive correlation between number of repeat units and magnitude of cohesive force, we designed a circular mRNA on which the OFR of TRn5 ( BBa_K5398001) between the 3' and 5' intron of td gene from T4 phage (BBa_K5398002 and BBa_K5398003). This strategy could use short sequences to express highly repetitive squid ring teeth proteins. A self-cleaving RNA cyclase ribozyme was incorporated to form the circular mRNAs, allowing ribosomes to repeatedly translate the sequence of interest and producing proteins with different repeat numbers, thus we could obtain proteins with exceptional self-healing properties.
Characterization
Protein expression
The synthetic plasmid pET29a(+)-cmRNA(TRn5) was transformed into E.coli BL21 (DE3) and recombinant proteins were expressed using LB medium (Fig. 3).
Fig. 3 The plasmid map of pET29a(+)-cmRNA(TRn5).
Self-healing test
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal XhoI site found at 35
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Reference
[1] LIU L, WANG P, ZHAO D, et al. Engineering Circularized mRNAs for the Production of Spider Silk Proteins[J]. Appl. Environ. Microbiol., 2022, 88(8): e00028-22.
[2] PERRIMAN R, ARES M. Circular mRNA can direct translation of extremely long repeating-sequence proteins in vivo[J]. RNA, 1998, 4(9): 1047-1054.
[3] LEE S O, XIE Q, FRIED S D. Optimized Loopable Translation as a Platform for the Synthesis of Repetitive Proteins[J]. ACS Cent. Sci., 2021, 7(10): 1736-1750.
[4] OBI P, CHEN Y G. The design and synthesis of circular RNAs[J]. Methods, 2021, 196: 85-103.
[5] GOMES R M O da S, SILVA K J G da, THEODORO R C. Group I introns: Structure, splicing and their applications in medical mycology[J]. Genet. Mol. Biol., 2024, 47: e20230228.